Sathya Jyothinagaram
Endocrinology, Diabetes & Metabolism · Phoenix, AZNPI 1538192703
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Merck at 51.9% of the total. Reporting peaked in 2019 at $8,695 and has fallen 97.8% since, to $194 in 2025.
Across 95 payments — averaging $107.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$5K
- Johnson & Johnson$3K
- AstraZeneca$507
- Boehringer Ingelheim$306
- Abbott$273
- Insulet Corporation$262
- plus $1K from 18 others
What the payments were for
- Speaking & faculty fees$6,12060%
- Travel & lodging$1,48314%
- Food & beverage$2,43824%
- Education$2002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 9 | $5,314 |
| Johnson & Johnson | 14 | $2,539 |
| AstraZeneca | 10 | $507 |
| Boehringer Ingelheim | 10 | $306 |
| Abbott | 7 | $273 |
| Insulet Corporation | 4 | $262 |
| Novo Nordisk | 7 | $207 |
| Tandem Diabetes Care, Inc. | 2 | $122 |
| Bayer | 1 | $117 |
| Lilly USA, LLC | 7 | $88 |
| Corcept Therapeutics | 2 | $88 |
| Amarin Pharma, Inc. | 1 | $87 |
| AbbVie(2 entities) | 5 | $83 |
| Medtronic | 3 | $56 |
| Amgen | 2 | $31 |
| Shire North American Group Inc | 2 | $26 |
| Dexcom, Inc. | 2 | $23 |
| Lifescan, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $18 |
| Radius Health, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Mannkind Corporation | 1 | $12 |
| Vivus LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STEGLATRO$5,240
- INVOKANA$2,327
- FARXIGA$239
- FreeStyle Lite system$200
- Omnipod$134
- Kerendia$117
- JARDIANCE$113
- t:slim X2 Insulin Pump with Control-IQ$104
How this compares
$10,241 in reported general payments places this provider in the 75th percentile of 148 endocrinology, diabetes & metabolism providers in Arizona.
See all endocrinology, diabetes & metabolism providers in Arizona →
Other endocrinology, diabetes & metabolism in Phoenix
- Kevin YuenPhoenix$404K
- Joan BaileyPhoenix$316K
- Anna BoronPhoenix$32K
- Kari EdlingPhoenix$23K
- James DeerPhoenix$13K
- Lory BarazPhoenix$10K
- Philip LevyPhoenix$9K
- Richard ArakakiPhoenix$6K
- Yasmin AkhunjiPhoenix$5K
- Ahmad Al MaradniPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.